Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PT Satoria Aneka Industri is an Indonesian pharmaceutical company specializing in the large-scale manufacture of intravenous (IV) solutions and sterile liquid products. As a core division of the Satoria Group, the company operates a state-of-the-art manufacturing facility in Pasuruan, East Java, utilizing advanced Blow-Fill-Seal (BFS) technology to ensure high sterility and efficiency. Their product portfolio includes essential medical fluids such as Normal Saline, Dextrose, and Ringer's Lactate, which are distributed to hospitals and healthcare providers across Indonesia and international markets. The company is recognized for its adherence to Good Manufacturing Practice (GMP) standards and plays a critical role in the regional supply chain for life-saving infusion therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PT Satoria Aneka Industri.